News

Filter

Current filters:

solithromycin

Cempra out-licenses solithromycin to Toyama Chemical in Japan

15-05-2013

USA-based clinical-stage antibiotics developer Cempra (Nasdaq: CEMP) has signed an exclusive license…

Antibiotics and Infectious diseasesAsia-PacificCempraLicensingPharmaceuticalsolithromycinToyama

Back to top